Skip to main content
editorial
. 2024 Oct 27;16(10):1142–1150. doi: 10.4254/wjh.v16.i10.1142

Figure 1.

Figure 1

Pathogenic factors and treatment of non-alcoholic steatohepatitis. NASH: Non-alcoholic steatohepatitis; SCFSs: Short-chain fatty acids; LPS: Lipopolysaccharide; TNF-α: Tumor Necrosis Factor-α; TLR4: Toll-like receptor 4; NF-κB: Nuclear factor kappa-B; GLP-1: Glucagon-like peptide-1; SGLT2i: Sodium-glucose cotransporter 2 inhibitors; PPAR α/β: Peroxisome proliferator-activated receptors α/β; FXR: Farnesoid X receptor; mAbs: Monoclonal antibodies.